Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies

Study finds new molecular pathways involved with autoimmune diseases, potential implications for therapies
Different arrangement of the IRF-4 (blue)/BATF-JunB (red) complex in different promoter sites leads to the activation of the Ctla-4 receptor and Bcl11b gene expression respectively. Credit: Carlos Escalante, Ph.D./VCU

Teamwork between a pair of transcription factors may be responsible for regulating the functioning of Th17 cells, which when found in excessive amounts are believed to play a major role in many autoimmune diseases, according to a study published last week in the journal Science by a national team of researchers.

The findings may help researchers develop potential therapies against autoimmune disease such as multiple sclerosis, psoriasis, , rheumatoid arthritis and .

The collaborative study was led by researchers at Genetech, Inc., in San Francisco, and included researchers from the Virginia Commonwealth University School of Medicine, the Howard Hughes Medical Institute in Chevy Chase, Md., the Washington University School of Medicine in St. Louis, the University of Chicago, New York University and the M.D. Anderson Cancer Center in Houston.

The team reported on new composite DNA sites that included binding sites for both IRF4 and BATF. The composite sites had variations in the spacing separating the two individual sites leading to different arrangement of the two . Transcription factors serve as traffic coordinators, controlling the flow of genetic information from DNA to mRNA.

The study shows that this different arrangement leads to the activation of different genes. Activation of several genes during differentiation of Th17 cells is promoted by the partnership of IRF4 and BATF.

"The work shows for the first time that the transcription factors IRF4 and BATF through cooperative binding to composite DNA sites are critical for the differentiation of T helper 17 cells," said study contributor Carlos R. Escalante, Ph.D., assistant professor in the Department of Physiology and Biophysics in the VCU School of Medicine. Escalante was involved in the generation of the atomic models of the different IRF4-BATF-DNA complexes.

add to favorites email to friend print save as pdf

Related Stories

Gene regulates immune cells' ability to harm the body

Jul 17, 2009

A recently identified gene allows immune cells to start the self-destructive processes thought to underlie autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis, researchers at Washington University ...

How proteins find their way on chromosomes

Jun 25, 2012

A research team at Uppsala University has managed to clarify how proteins that regulate the activity of genes quickly find their way on chromosomes among millions of possible binding sites. The study also confirms a more ...

Recommended for you

New perspective on sepsis

12 hours ago

In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis ...

Some immune cells defend only one organ

21 hours ago

(Medical Xpress)—Scientists have uncovered a new way the immune system may fight cancers and viral infections. The finding could aid efforts to use immune cells to treat illness.

User comments